Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Rie Jewson has worked on the following 11 EPO patent applications which have been published in the last five years:

EP11784095

NOVEL PROCESSES

IPC classification:
C07D 239/70
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
The patent has been granted
EP12738465

BICYCLIC PYRIMIDONE COMPOUNDS

IPC classification:
A61K 31/519, A61P 25/28, C07D 487/04
Applicant:
Glaxo Group Limited
Agent:
Rie Jewson, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12818124

2,3-DIHYDROIMIDAZO[1,2-C]PYRIMIDIN-5(1H)-ONE COMPOUNDS USE AS LP-PLA INHIBITORS

IPC classification:
A61K 31/519, A61P 9/10, A61P 25/28, C07D 487/04
Applicant:
Glaxo Group Limited
Agent:
Rie Jewson, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12756693

NOVEL CRYSTAL FORM

IPC classification:
A61K 31/4545, A61P 25/28, C07D 401/12
Applicant:
Glaxo Group Limited
Agent:
Rie Jewson, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14743086

BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Rie Jewson, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14743409

COMPOUNDS

IPC classification:
A61K 31/519, A61P 25/14, A61P 25/16, A61P 25/28, C07D 487/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Rie Jewson, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14701355

2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS

IPC classification:
A61K 31/519, A61P 25/28, C07D 487/04
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Rie Jewson, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11847368

COMPOUNDS

IPC classification:
A61K 31/4412, A61K 31/513, A61P 9/10, C07D 213/69, C07D 239/52, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/06
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11826309

TRICYCLIC COMPOUNDS, PREPARATION METHODS, AND THEIR USES

IPC classification:
A61K 31/519, A61P 3/08, A61P 7/00, A61P 25/00, A61P 27/02, C07D 471/04
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11802872

PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP-PLA2

IPC classification:
C07D 239/36, C07D 239/47, C07D 239/52, C07D 239/56, C07D 401/06, C07D 401/12, C07D 401/14, C07D 403/06, C07D 403/12, C07D 403/14, C07D 413/06, C07D 417/06
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15702008

HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE

IPC classification:
A61K 31/431, A61P 43/00, C07D 307/24, C07D 307/68, C07D 407/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Rie Jewson, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature